Journal of Medical Economics
Volume 26, 2023 - Issue 1
Open access
4,200
Views
1
CrossRef citations to date
0
Altmetric
Oncology
Cost effectiveness analysis of CAR-T cell therapy for patients with relapsed/refractory multiple myeloma in China
Weijia Wua Center for Health Policy Studies, School of Public Health, and Department of Science and Education of the Fourth Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
, Shuyi Dingb Nursing Department, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China;c Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
, Zhang Mingmingc Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China;d Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China;e Institute of Hematology, Zhejiang University, Hangzhou, China
, Zhou Yupingb Nursing Department, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China;c Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
, Xueshan Suna Center for Health Policy Studies, School of Public Health, and Department of Science and Education of the Fourth Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
, Zixuan Zhaoa Center for Health Policy Studies, School of Public Health, and Department of Science and Education of the Fourth Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
, Yi Yanga Center for Health Policy Studies, School of Public Health, and Department of Science and Education of the Fourth Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
, Yongxian Huc Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China;d Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China;e Institute of Hematology, Zhejiang University, Hangzhou, China
& Hengjin Donga Center for Health Policy Studies, School of Public Health, and Department of Science and Education of the Fourth Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaCorrespondence[email protected]
https://orcid.org/0000-0002-5064-7297
Pages 701-709
|
Received 01 Feb 2023, Accepted 24 Apr 2023, Published online: 21 May 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.